Licensing in Pharmaceuticals
We will introduce pipeline candidates such as biosimilars, biobetters, new synthetic compounds, and new formulation generics.
We are collecting candidate products without specifying a particular therapeutic area, focusing on novelty and innovation. As of now, our achievements include oncology, cell therapy, gastroenterology, respiratory medicine, dermatology, hematological diseases, radiology, analgesics, ophthalmology, and platform technologies.
- Company：リブラメディシーナ
- Price：Other
